OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea · Delayed Price · Currency is KRW 91,300
-2,700 (-2.87%)
Nov 2, 2026, 10:53 AM KST
OliX Pharmaceuticals Market Cap
OliX Pharmaceuticals has a market cap or net worth of 2.08 trillion as of October 30, 2026. It is the 7,657th most valuable company in the world and the 181st biggest in South Korea. Its market cap has decreased by 12.86% in one year.
Market Cap
2.08T
Enterprise Value
1.89T
Revenue
13.64B
Global Rank
Country Rank
#181 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 18, 2018, OliX Pharmaceuticals's market cap has increased from 422.03B to 2.08T, an increase of 392.18%. That is a compound annual growth rate of 21.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 2.08T | -26.72% |
| Dec 30, 2025 | 2.83T | 697.30% |
| Dec 30, 2024 | 355.53B | 52.22% |
| Dec 28, 2023 | 233.57B | -16.24% |
| Dec 29, 2022 | 278.86B | -50.37% |
| Dec 30, 2021 | 561.83B | -17.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 6.08T |
| HLB Co., Ltd. | 5.32T |
| SK bioscience | 2.56T |
| LigaChem Biosciences | 2.27T |
| ABL Bio | 2.19T |
| Peptron | 2.15T |
| Hugel | 1.94T |
| Voronoi | 1.92T |